Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An < em > in silico < /em > approach

CONCLUSIONS: In the current investigation, simeprevir was identified as the potential antiviral drug based on the in silico findings in comparison to remdesivir, favipiravir and other 53 drugs. Further, laboratory and clinical investigations are needed to be carried out which will aid in the development of quick therapeutics designed for COVID-19.PMID:33818470 | DOI:10.4103/ijmr.IJMR_1132_20
Source: Indian J Med Res - Category: Research Authors: Source Type: research